Drugs and drug-like molecules can modulate the function of mucosal-associated invariant T cells.
Keller, A.N., Eckle, S.B., Xu, W., Liu, L., Hughes, V.A., Mak, J.Y., Meehan, B.S., Pediongco, T., Birkinshaw, R.W., Chen, Z., Wang, H., D'Souza, C., Kjer-Nielsen, L., Gherardin, N.A., Godfrey, D.I., Kostenko, L., Corbett, A.J., Purcell, A.W., Fairlie, D.P., McCluskey, J., Rossjohn, J.(2017) Nat Immunol 18: 402-411
- PubMed: 28166217 
- DOI: 10.1038/ni.3679
- Primary Citation of Related Structures:  
5U16, 5U17, 5U1R, 5U2V, 5U6Q - PubMed Abstract: 
The major-histocompatibility-complex-(MHC)-class-I-related molecule MR1 can present activating and non-activating vitamin-B-based ligands to mucosal-associated invariant T cells (MAIT cells). Whether MR1 binds other ligands is unknown. Here we identified a range of small organic molecules, drugs, drug metabolites and drug-like molecules, including salicylates and diclofenac, as MR1-binding ligands ...